Abstract:
Antimicrobial cationic polymers having one or two cationic polycarbonate chains were prepared by organocatalyzed ring opening polymerization. One antimicrobial cationic polymer has a polymer chain consisting essentially of cationic carbonate repeat units linked to one or two end groups. The end groups can comprise a covalently bound form of biologically active compound such as cholesterol. Other antimicrobial cationic polymers have a random copolycarbonate chain comprising a minor mole fraction of hydrophobic repeat units bearing a covalently bound form of a vitamin E and/or vitamin D2. The cationic polymers exhibit high activity and selectivity against Gram-negative and Gram-positive microbes and fungi.
Abstract:
A system and method for human motion recognition are provided. The system includes a video sequence decomposer, a feature extractor, and a motion recognition module. The video sequence decomposer decomposes a video sequence into a plurality of atomic actions. The feature extractor extracts features from each of the plurality of atomic actions, the features including at least a motion feature and a shape feature. And the motion recognition module performs motion recognition for each of the plurality of atomic actions in response to the features.
Abstract:
Disclosed is a method for recovering stromal vascular fraction from a sample. The method comprises providing a mechanical force capable of breaking the sample into a single cell suspension whilst maintaining intact stromal vascular fraction cells cellular structures, wherein the mechanical force is mincing and/or homogenization. Also disclosed are methods of using the stromal vascular fraction.
Abstract:
A refractive index sensor is provided for analyzing an analyte, the sensor including: a strip waveguide for receiving an input light signal therein and transmitting the light signal, subject to manipulation as it propagates through the strip waveguide, to a detector for analysis with respect to the analyte; and a slot waveguide for sensing the analyte disposed thereon and for receiving a sensing signal, corresponding to said manipulation of the light signal, from the strip waveguide, wherein a grating is formed on a surface of the strip waveguide to enable coupling of the sensing signal from the strip waveguide to the slot waveguide, and the sensor is configured with enhanced sensitivity based on a sensitivity difference between the slot waveguide and the strip waveguide, and/or a group index difference between the slot waveguide and the strip waveguide.
Abstract:
An optical circuit for sensing a biological entity in a fluid and a method of configuring an optical circuit for sensing a biological entity in a fluid are provided. The optical circuit includes a sensing arrangement including a reference arm having a reference waveguide and a sensing arm having a waveguide; wherein lengths of the reference waveguide and the waveguide are configured in accordance with a temperature dependency reduction criterion.
Abstract:
A method for detecting and correcting an error in a circuit is provided. The circuit is configured to receive an input signal and clock the input signal with a rising and falling timing signal. The method includes detecting late arrival signal transition of the input signal, at an intermediate point of a path, the path being one through which the input signal transits. The method further includes predicting an error in the input signal in response to detecting the late arrival signal transition at the intermediate point of the path. In addition, the method includes correcting the error in the input signal by manipulating the timing signal and/or a supply voltage.
Abstract:
We provide an antibody capable of binding to an intracellular PRL-I or PRL-3 polypeptide, in which the antibody is capable of binding to an epitope bound by antibody 269, antibody 223 or antibody 318. Such anti-PRL antibodies may be capable of binding to intracellular PRL-I or PRL-3. They may be suitable for use as therapies against cancer or metastasis thereof, or in clinical diagnosis to identify PRL-3 or PRL-I positive patients.
Abstract:
Water soluble biodegradable polymers were prepared by an organoacid catalyzed ring opening polymerization (ROP) of a cyclic carbonate monomer bearing an active ester side chain. The initial polymer comprising an active ester side chain was treated with an amino-alcohol, which transformed the active ester groups to N-substituted amide groups bearing mono-hydroxy alkyl groups and/or dihydroxy alkyl groups, thereby forming the water soluble polymers. The water-soluble polymers are non-toxic and exhibit stealth properties in buffered serum solution.
Abstract:
The present invention provides the use of a metal-doped hydroxyapatite catalyst for highly selective conversion of an alcohol to an aldehyde at low temperatures. More specifically, the invention provides the use of a silver-doped hydroxyapatite catalyst for the highly selective oxidative dehydrogenation of ethanol to acetaldehyde. The present invention also provides the method for converting ethanol to acetaldehyde using a silver-doped hydroxyapatite catalyst.